Trade Summary

2 days ago, Camblong Jurgi, serving as Executive Chairman at SOPHiA GENETICS SA (SOPH), sold 83,679 shares at $6.06 per share, for a total transaction value of $506,690.29. Following this transaction, Camblong Jurgi now holds 3,581,293 shares of SOPH.

This sale represents a 2.28% decrease in Camblong Jurgi's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, June 29, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, July 1, 2026 at 4:03 PM ET, 2 days after the trade was made.

SOPHiA GENETICS SA operates in the HEALTHCARE sector, specifically within the HEALTH INFORMATION SERVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.